# Ainos, Inc.: financial statements, quarterly

AIMD · Nasdaq · CIK 1014763 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aimd.md) · [Financials](/companies/aimd/financials.md) · [Filings](/companies/aimd/filings.md) · [Insiders](/companies/aimd/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/aimd/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [24.5](/filings/0001493152-24-043832.md) | [19.9 d](/filings/0001493152-25-009568.md) | [20.7](/filings/0001641172-25-010264.md) | [0.0 d](/filings/0001493152-25-011908.md) | [0.0 d](/filings/0001493152-25-022312.md) | [0.0 d](/filings/0001493152-26-013579.md) | [106](/filings/0001493152-26-022791.md) | [4.7](/filings/0001493152-26-035833.md) | [2.2](/filings/0001493152-25-022312.md) | [11.1 d](/filings/0001493152-26-013579.md) | [0.2](/filings/0001493152-26-022791.md) | [0.2](/filings/0001493152-26-035833.md) |
| Cost of revenue | $k | [87.9](/filings/0001493152-24-043832.md) | [131 d](/filings/0001493152-25-009568.md) | [26.8](/filings/0001641172-25-010264.md) | [25.4](/filings/0001493152-25-011908.md) | [0.5](/filings/0001493152-25-022312.md) | [(0.1) d](/filings/0001493152-26-013579.md) | [18.2](/filings/0001493152-26-022791.md) | [0.9](/filings/0001493152-26-035833.md) | [0.5](/filings/0001493152-25-022312.md) | [1.6 d](/filings/0001493152-26-013579.md) | [0.8](/filings/0001493152-26-022791.md) | [0.1](/filings/0001493152-26-035833.md) |
| Gross profit | $k | [(63.4)](/filings/0001493152-24-043832.md) | [(111) d](/filings/0001493152-25-009568.md) | [(6.0)](/filings/0001641172-25-010264.md) | [(25.4)](/filings/0001493152-25-011908.md) | [(0.5)](/filings/0001493152-25-022312.md) | [0.1 d](/filings/0001493152-26-013579.md) | [88.0](/filings/0001493152-26-022791.md) | [3.7](/filings/0001493152-26-035833.md) | [1.7](/filings/0001493152-25-022312.md) | [9.5 d](/filings/0001493152-26-013579.md) | [(0.6)](/filings/0001493152-26-022791.md) | [0.1](/filings/0001493152-26-035833.md) |
| Research and development | $k | [1,710](/filings/0001493152-24-043832.md) | [2,237 d](/filings/0001493152-25-009568.md) | [2,085](/filings/0001641172-25-010264.md) | [1,979](/filings/0001493152-25-011908.md) | [2,022](/filings/0001493152-25-022312.md) | [2,328 d](/filings/0001493152-26-013579.md) | [1,724](/filings/0001493152-26-022791.md) | [1,912](/filings/0001493152-26-035833.md) | [1,991](/filings/0001493152-25-022312.md) | [2,123 d](/filings/0001493152-26-013579.md) | [1,690](/filings/0001493152-26-022791.md) | [1,850](/filings/0001493152-26-035833.md) |
| Selling, general and administrative | $k | [902](/filings/0001493152-24-043832.md) | [3,353 d](/filings/0001493152-25-009568.md) | [1,029](/filings/0001641172-25-010264.md) | [1,045](/filings/0001493152-25-011908.md) | [1,016](/filings/0001493152-25-022312.md) | [2,305 d](/filings/0001493152-26-013579.md) | [1,527](/filings/0001493152-26-022791.md) | [1,838](/filings/0001493152-26-035833.md) | [795](/filings/0001493152-25-022312.md) | [2,184 d](/filings/0001493152-26-013579.md) | [593](/filings/0001493152-26-022791.md) | [2,549](/filings/0001493152-26-035833.md) |
| Operating income | $k | [(2,676)](/filings/0001493152-24-043832.md) | [(5,701) d](/filings/0001493152-25-009568.md) | [(3,120)](/filings/0001641172-25-010264.md) | [(3,049)](/filings/0001493152-25-011908.md) | [(3,039)](/filings/0001493152-25-022312.md) | [(4,634) d](/filings/0001493152-26-013579.md) | [(3,163)](/filings/0001493152-26-022791.md) | [(3,746)](/filings/0001493152-26-035833.md) | [(2,784)](/filings/0001493152-25-022312.md) | [(4,298) d](/filings/0001493152-26-013579.md) | [(2,284)](/filings/0001493152-26-022791.md) | [(4,399)](/filings/0001493152-26-035833.md) |
| Interest expense | $k | [44.3](/filings/0001654954-24-001834.md) | [50.3 d](/filings/0001654954-24-002897.md) | [48.7](/filings/0001493152-24-018885.md) | [119](/filings/0001493152-25-011908.md) | [265](/filings/0001493152-25-022312.md) | [184 d](/filings/0001493152-26-013579.md) | [180](/filings/0001493152-26-022791.md) | [178](/filings/0001493152-26-035833.md) | [177](/filings/0001493152-25-022312.md) | [177 d](/filings/0001493152-26-013579.md) | [177](/filings/0001493152-26-022791.md) | [200](/filings/0001493152-26-035833.md) |
| Income tax | $k | [0.0](/filings/0001654954-24-001834.md) | [0.8 d](/filings/0001493152-25-009568.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | [(2,976)](/filings/0001493152-24-043832.md) | [(5,925) d](/filings/0001493152-25-009568.md) | [(3,315)](/filings/0001641172-25-010264.md) | [(3,195)](/filings/0001493152-25-011908.md) | [(3,699)](/filings/0001493152-25-022312.md) | [(4,654) d](/filings/0001493152-26-013579.md) | [(3,286)](/filings/0001493152-26-022791.md) | [(4,085)](/filings/0001493152-26-035833.md) | [(2,932)](/filings/0001493152-25-022312.md) | [(4,468) d](/filings/0001493152-26-013579.md) | [(2,460)](/filings/0001493152-26-022791.md) | [(4,595)](/filings/0001493152-26-035833.md) |
| Diluted EPS | $ per share | [(0.73)](/filings/0001493152-24-043832.md) | not reported | [(0.57)](/filings/0001641172-25-010264.md) | [(2.45)](/filings/0001493152-25-011908.md) | [(1.64)](/filings/0001493152-25-022312.md) | not reported | [(1.04)](/filings/0001493152-26-022791.md) | [(0.99)](/filings/0001493152-26-035833.md) | [(0.64)](/filings/0001493152-25-022312.md) | not reported | [(0.41)](/filings/0001493152-26-022791.md) | [(0.62)](/filings/0001493152-26-035833.md) |
| Basic EPS | $ per share | [(0.73)](/filings/0001493152-24-043832.md) | not reported | [(0.57)](/filings/0001641172-25-010264.md) | [(2.45)](/filings/0001493152-25-011908.md) | [(1.64)](/filings/0001493152-25-022312.md) | not reported | [(1.04)](/filings/0001493152-26-022791.md) | [(0.99)](/filings/0001493152-26-035833.md) | [(0.64)](/filings/0001493152-25-022312.md) | not reported | [(0.41)](/filings/0001493152-26-022791.md) | [(0.62)](/filings/0001493152-26-035833.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [2.4](/filings/0001654954-24-001834.md) | [1.9](/filings/0001493152-25-009568.md) | [1.0](/filings/0001493152-24-018885.md) | [8.0](/filings/0001493152-24-030251.md) | [5.2](/filings/0001493152-24-043832.md) | [3.9](/filings/0001493152-26-013579.md) | [2.6](/filings/0001641172-25-010264.md) | [1.2](/filings/0001493152-25-011908.md) | [1.1](/filings/0001493152-25-022312.md) | [0.4](/filings/0001493152-26-035833.md) | [2.8](/filings/0001493152-26-022791.md) | [1.4](/filings/0001493152-26-035833.md) |
| Current assets | $m | [3.0](/filings/0001654954-24-001834.md) | [2.5](/filings/0001493152-25-009568.md) | [1.5](/filings/0001493152-24-018885.md) | [8.5](/filings/0001493152-24-030251.md) | [5.6](/filings/0001493152-24-043832.md) | [4.3](/filings/0001493152-26-013579.md) | [3.1](/filings/0001641172-25-010264.md) | [1.7](/filings/0001493152-25-011908.md) | [1.7](/filings/0001493152-25-022312.md) | [1.1](/filings/0001493152-26-035833.md) | [3.5](/filings/0001493152-26-022791.md) | [2.2](/filings/0001493152-26-035833.md) |
| Total assets | $m | [33.9](/filings/0001654954-24-001834.md) | [31.8](/filings/0001493152-25-009568.md) | [29.8](/filings/0001493152-24-018885.md) | [35.5](/filings/0001493152-24-030251.md) | [31.4](/filings/0001493152-24-043832.md) | [28.8](/filings/0001493152-26-013579.md) | [26.4](/filings/0001641172-25-010264.md) | [23.9](/filings/0001493152-25-011908.md) | [22.7](/filings/0001493152-25-022312.md) | [20.9](/filings/0001493152-26-035833.md) | [22.1](/filings/0001493152-26-022791.md) | [19.6](/filings/0001493152-26-035833.md) |
| Current liabilities | $m | [0.8](/filings/0001654954-24-001834.md) | [1.3](/filings/0001493152-25-009568.md) | [4.7](/filings/0001493152-24-018885.md) | [5.7](/filings/0001493152-24-030251.md) | [4.1](/filings/0001493152-24-043832.md) | [4.0](/filings/0001493152-26-013579.md) | [1.5](/filings/0001641172-25-010264.md) | [0.6](/filings/0001493152-25-011908.md) | [0.6](/filings/0001493152-25-022312.md) | [1.1](/filings/0001493152-26-035833.md) | [6.3](/filings/0001493152-26-022791.md) | [16.3](/filings/0001493152-26-035833.md) |
| Total liabilities | $m | [6.2](/filings/0001654954-24-001834.md) | [7.4](/filings/0001493152-25-009568.md) | [7.1](/filings/0001493152-24-018885.md) | [14.8](/filings/0001493152-24-030251.md) | [13.3](/filings/0001493152-24-043832.md) | [13.3](/filings/0001493152-26-013579.md) | [13.2](/filings/0001641172-25-010264.md) | [12.5](/filings/0001493152-25-011908.md) | [12.6](/filings/0001493152-25-022312.md) | [13.3](/filings/0001493152-26-035833.md) | [16.4](/filings/0001493152-26-022791.md) | [16.3](/filings/0001493152-26-035833.md) |
| Shareholders' equity | $m | [27.7](/filings/0001493152-24-043832.md) | [24.4](/filings/0001493152-26-013579.md) | [22.7](/filings/0001493152-25-011908.md) | [20.7](/filings/0001493152-25-022312.md) | [18.0](/filings/0001493152-25-022312.md) | [15.5](/filings/0001493152-26-035833.md) | [13.1](/filings/0001493152-26-035833.md) | [11.4](/filings/0001493152-26-035833.md) | [10.0](/filings/0001493152-25-022312.md) | [7.6](/filings/0001493152-26-035833.md) | [5.7](/filings/0001493152-26-035833.md) | [3.3](/filings/0001493152-26-035833.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(743) d](/filings/0001493152-24-043832.md) | [(1,373) d](/filings/0001493152-25-009568.md) | [(1,495)](/filings/0001641172-25-010264.md) | [(1,974) d](/filings/0001493152-25-011908.md) | [(1,475) d](/filings/0001493152-25-022312.md) | [(864) d](/filings/0001493152-26-013579.md) | [(1,225)](/filings/0001493152-26-022791.md) | [(1,350) d](/filings/0001493152-26-035833.md) | [(1,185) d](/filings/0001493152-25-022312.md) | [(855) d](/filings/0001493152-26-013579.md) | [(983)](/filings/0001493152-26-022791.md) | [(1,448) d](/filings/0001493152-26-035833.md) |
| Capital expenditure | $k | [36.6 d](/filings/0001493152-24-043832.md) | [(14.9) d](/filings/0001493152-25-009568.md) | [4.4](/filings/0001641172-25-010264.md) | [5.8 d](/filings/0001493152-25-011908.md) | [10.1 d](/filings/0001493152-25-022312.md) | [0.9 d](/filings/0001493152-26-013579.md) | [33.6](/filings/0001493152-26-022791.md) | [(7.7) d](/filings/0001493152-26-035833.md) | [10.1 d](/filings/0001493152-25-022312.md) | [(1.5) d](/filings/0001493152-26-013579.md) | [8.5](/filings/0001493152-26-022791.md) | [5.8 d](/filings/0001493152-26-035833.md) |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2014 (2014-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [73.3](/filings/0001014763-14-000017.md) | [4.0](/filings/0001493152-24-018885.md) | [4.0](/filings/0001493152-24-030251.md) | [4.1](/filings/0001493152-24-043832.md) | [5.8](/filings/0001641172-25-010264.md) | [1.3](/filings/0001493152-25-011908.md) | [2.3](/filings/0001493152-25-022312.md) | [3.2](/filings/0001493152-26-022791.md) | [4.1](/filings/0001493152-26-035833.md) | [4.6](/filings/0001493152-25-022312.md) | [6.0](/filings/0001493152-26-022791.md) | [7.4](/filings/0001493152-26-035833.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 7,384,073 at 2026-08-03, from the cover of the [10-Q filed 2026-08-03](/filings/0001493152-26-035833.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.